| Variables |
IVIG (mean ± SE) N=42 |
Placebo (mean ± SE) N=44 |
P value |
| FS% |
16.6 ± 0.6 |
17.3 ± 0.8 |
>0.05 |
| LVEDD(mm) |
44.7 ± 1.2 |
47.5 ± 1.6 |
>0.05 |
| Hb (gm/dl) |
10.3 ± 0.2 |
10.2 ± 0.2 |
>0.05 |
| WBCs |
10.1 ± 0.6 |
9.2 ± 0.6 |
>0.05 |
| ESR |
16.1 ± 1.7 |
14.8 ± 1.3 |
>0.05 |
| CPK(U/L) |
155.6 ± 33.9 |
243.2 ± 34.2 |
0.002* |
| LDL(U/L) |
534.0 ± 83.9 |
644.8 ± 174.7 |
>0.05 |
| CKMB(U/L) |
91.2 ± 33.6 |
130.8 ± 76.2 |
>0.05 |
| HR |
123.4 ± 3.9 |
126.4 ± 3.2 |
>0.05 |
| P-R interval |
143.6 ± 11.6 |
127.3 ± 2.7 |
>0.05 |
| QRS duration |
85.4 ± 1.7 |
96.6 ± 5.8 |
>0.05 |
|
